Department of Clinical Laboratory and Hematology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China, Zhenjiang, Jiangsu 212013, PR China.
Department of Clinical Laboratory and Hematology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China, Zhenjiang, Jiangsu 212013, PR China.
Cell Signal. 2019 May;57:29-44. doi: 10.1016/j.cellsig.2019.02.002. Epub 2019 Feb 7.
In our previous study, the oxLDL/βGPI/anti-βGPI complex was demonstrated to further enhance the foam cell formation and migration of VSMC, as well as the expression of inflammatory cytokines, via the TLR4/NF-κB pathway. However, sparse information is available on other pro-atherogenic pathogenic effects of the oxLDL/βGPI/anti-βGPI complex, such as effects on proliferation and apoptosis. In the present study, we focused on the biphasic effects and underlying mechanisms of the oxLDL/βGPI/anti-βGPI complex on VSMC survival. The data showed that short exposure to the oxLDL/βGPI/anti-βGPI complex could activate NF-κB and ERK1/2 pathways and stimulate cell proliferation in VSMC. In contrast, longer exposure increased the level of p38 pathway activation and cell apoptosis. Additionally, the promotion effect of the oxLDL/βGPI/anti-βGPI complex on both proliferation and apoptosis, as well as signaling pathway activation, was stronger than that of the other control groups. The use of selective blockers showed that TLR4/NF-κB and ERK1/2 partly mediated oxLDL/βGPI/anti-βGPI complex-induced proliferation and had an inhibitory effect on complex-stimulated apoptosis. Conversely, TLR2/p38 partly mediated oxLDL/βGPI/anti-βGPI complex-induced apoptosis and had a negative effect on complex-stimulated proliferation. Specific inhibitors of NF-κB and ERK1/2 activation could augment the oxLDL/βGPI/anti-βGPI complex-induced phosphorylation of p38 and vice versa. Under pretreatment with NADPH oxidase inhibitors, intracellular ROS generation was confirmed to participate in oxLDL/βGPI/anti-βGPI complex-induced proliferation and apoptosis, as well as the phosphorylation of NF-κB and MAPKs. Taken together, our data clearly revealed that the oxLDL/βGPI/anti-βGPI complex had biphasic effects on VSMC survival, partly mediated by ROS-induced NF-κB and MAPKs activation. The TLR4/NF-κB and TLR2/p38 pathways played supporting roles in this dual effects-initiated signal network, and there is a trade-off relationship between the phosphorylation of NF-κB, ERK1/2 and p38. The dual effects of the oxLDL/βGPI/anti-βGPI complex on VSMC survival contribute to the development of the structure typical of atherosclerotic lesions, particularly focal excessive growth alternating with necrosis.
在我们之前的研究中,已经证明 oxLDL/βGPI/抗-βGPI 复合物通过 TLR4/NF-κB 途径进一步增强了泡沫细胞的形成和 VSMC 的迁移,以及炎症细胞因子的表达。然而,关于 oxLDL/βGPI/抗-βGPI 复合物的其他促动脉粥样硬化致病作用的信息很少,例如对增殖和凋亡的影响。在本研究中,我们专注于 oxLDL/βGPI/抗-βGPI 复合物对 VSMC 存活的双相作用及其潜在机制。研究数据表明,短暂暴露于 oxLDL/βGPI/抗-βGPI 复合物可激活 NF-κB 和 ERK1/2 途径并刺激 VSMC 增殖。相反,较长时间的暴露增加了 p38 途径的激活和细胞凋亡水平。此外,oxLDL/βGPI/抗-βGPI 复合物对增殖和凋亡以及信号通路激活的促进作用强于其他对照组。使用选择性阻滞剂表明,TLR4/NF-κB 和 ERK1/2 部分介导了 oxLDL/βGPI/抗-βGPI 复合物诱导的增殖,并对复合物刺激的凋亡具有抑制作用。相反,TLR2/p38 部分介导了 oxLDL/βGPI/抗-βGPI 复合物诱导的凋亡,并对复合物刺激的增殖具有负作用。NF-κB 和 ERK1/2 激活的特异性抑制剂可增强 oxLDL/βGPI/抗-βGPI 复合物诱导的 p38 磷酸化,反之亦然。在 NADPH 氧化酶抑制剂预处理下,证实细胞内 ROS 的产生参与了 oxLDL/βGPI/抗-βGPI 复合物诱导的增殖和凋亡以及 NF-κB 和 MAPKs 的磷酸化。综上所述,我们的数据清楚地表明,oxLDL/βGPI/抗-βGPI 复合物对 VSMC 的存活具有双相作用,部分通过 ROS 诱导的 NF-κB 和 MAPKs 激活介导。TLR4/NF-κB 和 TLR2/p38 途径在这个双效信号网络的启动中发挥了支持作用,并且 NF-κB、ERK1/2 和 p38 的磷酸化之间存在权衡关系。oxLDL/βGPI/抗-βGPI 复合物对 VSMC 存活的双重作用有助于形成典型的动脉粥样硬化病变结构,特别是坏死与过度生长交替的局灶性过度生长。